HIV/AIDS researchers are potentially on the cusp of myriad innovative ways to prevent HIV transmission—from the development of a microbicide to Pre-exposure prophylaxis (PrEP). But while we wait with baited breath for clinical trial results, some advocates are focused on reviving old approaches, namely the female condom. As we noted in an earlier post on this […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]